Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Goette

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
Circulation|January 30, 2008
Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expressionAndreas Goette, Alicja Bukowska, Uwe Lendeckel, et al.
The American Journal of Cardiology|December 12, 2018
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)Gregory Y H Lip, Jose L Merino, Maciej Banach, et al.
European Journal of Heart Failure|March 19, 2025
Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESCBulent Gorenek, Adrianus P Wijnmaalen, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 13, 2024
Ventricular arrhythmias in acute heart failure: a clinical consensus statement of the Association for Acute CardioVascular Care, the European Heart Rhythm Association, and the Heart Failure Association of the European Society of CardiologyBulent Gorenek, Adrianus P Wijnmaalen, Andreas Goette, et al.
Cardiovascular Research|February 19, 2015
Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive ratsFlorentina Pluteanu, Johannes Heß, Jelena Plackic, et al.
The Lancet. Neurology|December 14, 2022
Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trialMärit Jensen, Anna Suling, Andreas Metzner, et al.
The American Journal of Cardiology|November 25, 2017
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)Gregory Y H Lip, Jose L Merino, G Andrei Dan, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 21, 2019
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillationGiuseppe Boriani, Carina Blomström-Lundqvist, Stefan H Hohnloser, et al.
Lancet (London, England)|August 19, 2014
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trialGerhard Hindricks, Milos Taborsky, Michael Glikson, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Circulation|January 30, 2008
Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expressionAndreas Goette, Alicja Bukowska, Uwe Lendeckel, et al.
The American Journal of Cardiology|December 12, 2018
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)Gregory Y H Lip, Jose L Merino, Maciej Banach, et al.
European Journal of Heart Failure|March 19, 2025
Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESCBulent Gorenek, Adrianus P Wijnmaalen, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 13, 2024
Ventricular arrhythmias in acute heart failure: a clinical consensus statement of the Association for Acute CardioVascular Care, the European Heart Rhythm Association, and the Heart Failure Association of the European Society of CardiologyBulent Gorenek, Adrianus P Wijnmaalen, Andreas Goette, et al.
Cardiovascular Research|February 19, 2015
Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive ratsFlorentina Pluteanu, Johannes Heß, Jelena Plackic, et al.
The Lancet. Neurology|December 14, 2022
Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trialMärit Jensen, Anna Suling, Andreas Metzner, et al.
The American Journal of Cardiology|November 25, 2017
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study)Gregory Y H Lip, Jose L Merino, G Andrei Dan, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 21, 2019
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillationGiuseppe Boriani, Carina Blomström-Lundqvist, Stefan H Hohnloser, et al.
Lancet (London, England)|August 19, 2014
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trialGerhard Hindricks, Milos Taborsky, Michael Glikson, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
Pageof 20